- Trials with a EudraCT protocol (104)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
104 result(s) found for: Alcohol consumption.
Displaying page 1 of 6.
EudraCT Number: 2007-002334-11 | Sponsor Protocol Number: 12014A | Start Date*: 2009-03-13 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: Nalmefene Efficacy Study I: Randomised, double-blind, placebo-controlled, parallel-group, efficacy study of 20 mg nalmefene, as needed use, in patients with alcohol dependence | |||||||||||||
Medical condition: Alcohol dependence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) SE (Completed) FI (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002563-27 | Sponsor Protocol Number: 12023A | Start Date*: 2008-11-24 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: Nalmefene Efficacy Study II: Randomised, double-blind, placebo-controlled, parallel-group, efficacy study of 20 mg nalmefene, as needed use, in patients with alcohol dependence | |||||||||||||
Medical condition: Alcohol dependence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) PT (Completed) ES (Completed) IT (Completed) BE (Completed) PL (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002831-16 | Sponsor Protocol Number: TUD-TEMANX-065 | Start Date*: 2015-10-20 | |||||||||||
Sponsor Name:Technische Universität Dresden | |||||||||||||
Full Title: Validation of a test system for development of medications for alcoholism | |||||||||||||
Medical condition: male and female volunteers aged 25-55 years with moderate risky alcohol consumption of at least 41 g/day (men) or 31 g/day (women), according to European Medicines Agency (EMA, 2010) this is at lea... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002315-92 | Sponsor Protocol Number: 12013A | Start Date*: 2008-11-12 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: A 52-week, randomised, double-blind, placebo-controlled, parallel-group, safety, tolerability and efficacy study of nalmefene, as needed use, in patients with alcohol dependence | |||||||||||||
Medical condition: Alcohol dependence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) SK (Completed) EE (Completed) GB (Completed) LV (Completed) HU (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000713-37 | Sponsor Protocol Number: 127 | Start Date*: 2006-02-20 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Intervention Baclofen Intervention Study | |||||||||||||
Medical condition: treatment of dependence in alcohol addiction | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004740-30 | Sponsor Protocol Number: PHRCN2018 | Start Date*: 2021-09-15 | |||||||||||
Sponsor Name:Centre Hospitalier Le Vinatier | |||||||||||||
Full Title: Cannabidiol for reducing drinking in alcohol use disorder and modifying the effects of alcohol on the brain and the liver: a phase 2 clinical trial. | |||||||||||||
Medical condition: CARAMEL is an exploratory phase-2 study conducted in subjects with AUD (alcohol use disorder) and current heavy drinking level, aiming to confirm the different properties of CBD observed in animal ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015537-67 | Sponsor Protocol Number: 2009-08-17 | Start Date*: 2009-11-23 | |||||||||||
Sponsor Name:Universitätsmedizin der Johannes Gutenberg-Universität Mainz | |||||||||||||
Full Title: Untersuchung der Wirksamkeit und Sicherheit von Vareniclin in der Postakutbehandlung der Alkoholabhängigkeit - eine prospektive, bizentrische, doppelblinde, placebokontrollierte, randomisierte Phas... | |||||||||||||
Medical condition: Alcohol dependence | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001990-25 | Sponsor Protocol Number: BO1 | Start Date*: 2004-09-06 |
Sponsor Name:Bo Söderpalm | ||
Full Title: Hur påverkar Remeron alkoholkonsumtionen? How will Remeron influence alcohol consumption in high consumers? | ||
Medical condition: The subjects in the study will be recruited via an advertisment and will not have a diagnos. We will include males with high consumption of alcohol, defines as 400 grams or more of 100% alcohol per... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-007090-72 | Sponsor Protocol Number: lpdc07 | Start Date*: 2007-10-17 | |||||||||||
Sponsor Name:Central Institute of Mental Health | |||||||||||||
Full Title: The role of the glutamatergic system in the extinction of conditioned reinforcement processes | |||||||||||||
Medical condition: Alcohol-dependence is an important factor contributing to health care costs. Alcohol-dependent patients show conditioned reactions to stimuli that were associated with substance consumption and sev... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000069-57 | Sponsor Protocol Number: P15-01 | Start Date*: 2017-07-21 | |||||||||||
Sponsor Name:BIOPROJET PHARMA | |||||||||||||
Full Title: A Multisite Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment | |||||||||||||
Medical condition: Male or female with moderate or severe DSM-5 alcohol use disorder (based on the alcohol use disorders section of MINI) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000413-31 | Sponsor Protocol Number: 15871A | Start Date*: 2014-07-24 | ||||||||||||||||
Sponsor Name:H. Lundbeck A/S | ||||||||||||||||||
Full Title: Exploratory, interventional, open-label, fixed-dose study with Selincro® as-needed use, in alcohol dependent patients with liver impairment | ||||||||||||||||||
Medical condition: Alcohol dependence and liver impairment related to alcohol consumption | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-001154-98 | Sponsor Protocol Number: 15660A | Start Date*: 2013-10-14 | |||||||||||
Sponsor Name:H Lundbeck A/S
[...]
1. H Lundbeck A/S
2. |
|||||||||||||
Full Title: Interventional, randomized, double-blind, cross-over, placebo-controlled study to investigate the effects of nalmefene after single dose on the blood oxygen level dependent (BOLD) fMRI signal in th... | |||||||||||||
Medical condition: Nalmefene (Selincro) is indicated for the reduction of alcohol consumption in adults with alcohol dependence who have a high drinking risk level, without physical withdrawal symptoms and who do not... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003343-11 | Sponsor Protocol Number: GLP1ALCOHOL | Start Date*: 2017-04-12 | |||||||||||
Sponsor Name:Psychiatric Centre Copenhagen | |||||||||||||
Full Title: Does Glucagon-like Peptide 1 (GLP-1) receptor stimulation reduce alcohol intake in patients with alcohol dependence? | |||||||||||||
Medical condition: Alcohol dependence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000048-24 | Sponsor Protocol Number: COMB-BO8 | Start Date*: 2018-12-28 |
Sponsor Name:Sahlgrenska University Hospital/VGR | ||
Full Title: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER TRIAL ON THE EFFICACY OF VARENICLINE AND BUPROPION, IN COMBINATION AND ALONE, FOR THE TREATMENT OF ALCOHOL USE DISORDER | ||
Medical condition: Alcohol Use Disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004688-30 | Sponsor Protocol Number: 15892A | Start Date*: 2014-05-19 | ||||||||||||||||
Sponsor Name:H. Lundbeck A/S | ||||||||||||||||||
Full Title: Interventional, open-label study of 18 mg Selincro® as needed use, in the treatment of patients with alcohol dependence in primary care | ||||||||||||||||||
Medical condition: Alcohol Dependency | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) DE (Completed) ES (Completed) IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-004954-99 | Sponsor Protocol Number: BO2 | Start Date*: 2008-08-21 |
Sponsor Name:Göteborg University, Sect. Psyhiatry and Neurochemistry
[...]
1. Göteborg University, Sect. Psyhiatry and Neurochemistry
2. Göteborg University, Sect. Psychiatry and Neurochemistry |
||
Full Title: Does varenicline influence alcohol consumption in alcohol dependent individuals? | ||
Medical condition: Alcohol dependence Nicotine dependence in alcohol dependent individuals | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001834-33 | Sponsor Protocol Number: OXYLIFE | Start Date*: 2020-10-20 |
Sponsor Name:LABORATORIO FARMACEUTICO CT SRL | ||
Full Title: Efficacy and safety of Sodium Oxybate in reducing alcohol consumption and maintaining abstinence in alcohol-dependent subjects with high and very high drinking risk level. “OXYLIFE Study“ | ||
Medical condition: Alcohol addiction | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IT (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003133-34 | Sponsor Protocol Number: OSU1 | Start Date*: 2012-02-29 |
Sponsor Name:A. Carlsson Research AB | ||
Full Title: The Effects of the Dopamine Stabilizer (-)-OSU6162 on Craving and Impulsivity in Alcohol Dependent Patients | ||
Medical condition: Alcohol dependence | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000829-55 | Sponsor Protocol Number: PSILO4ALCO | Start Date*: 2020-12-16 | ||||||||||||||||
Sponsor Name:Psychiatric Centre Copenhagen | ||||||||||||||||||
Full Title: Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial. | ||||||||||||||||||
Medical condition: Alcohol Use Disorder | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000207-90 | Sponsor Protocol Number: P15-14/BF2.649 | Start Date*: 2016-11-24 | |||||||||||
Sponsor Name:BIPROJET PHARMA | |||||||||||||
Full Title: A Multisite Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Pitolisant (BF2.649) For Alcohol Use Disorder Treatment. | |||||||||||||
Medical condition: Patients with moderate to severe alcohol use disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
